The Infertility Drugs Market is valued at USD 4.1 Bn in 2026.
The Infertility Drugs Market is projected to register a CAGR of 6% by 2033.
The market growth is driven by declining fertility rates, rising lifestyle disorders, and increasing adoption of fertility treatments.
North America is the dominant regional market for infertility drugs.
Merck & Co., Inc., Ferring B.V., Organon Group of Companies, Bayer AG, and Pfizer Inc. are some leading industry players in the infertility drugs market.